NASDAQ IMMY

Below are certain reports and other statements that we file with the Securities and Exchange Commission. Select the filing type you wish to view from the menus below.

The reports and other statements filed by Imprimis with the Securities and Exchange Commission are current and accurate only as of their respective dates, and Imprimis disclaims any responsibility to update or amend any information contained in such filings. Each filing Imprimis makes with the SEC contains certain information as required by applicable SEC rules and regulations, and may not provide a complete description of the company’s business.
Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.